Home > Publications & Reports 2007
 
 
 
 
 
| 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
| 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |

2007 - Click the links to read abstracts.

  1. Blume-Peytavi, Shapiro, et al. Unwanted Facial Hair: Affects, Effects and Solutions. Dermatology 2007;215:139-146.
  2. Carruthers A, Carruthers J, Cohen J. Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter? Dermatol Surg. 2007 Jan;33(1 Spec No.):S97-104.
  3. Bruecks, Kalia, Trotter. Overexpression of p27 KIP1 in Seborrheic Keratosis. J Cutan Med Surg 2007;11:5, 174-178.
  4. Carruthers A, Carruthers J. Eyebrow height after botulinum toxin type A to the glabella. Dermatol Surg. 2007 Jan;33(1 Spec No.):S26-31.
  5. Carruthers A, Carruthers J. Foreword to 2007 Special Issue on Botulinum Toxin. Dermatol Surg. 2007 Jan;33(1 Spec No.):S1-2.
  6. Chen R, Huang Z, Lui H, Hamzavi I, McLean DI, Xie S, Zeng H. Monte Carlo simulation of cutaneous reflectance and fluorescence measurements – The effect of melanin contents and localization. J Photochem Photobiol B-Bio 2007;86: 219-226
  7. Chen X, Kwak S, Lafleur M, Bloom M, Kitson N, Thewalt J. Fatty acids influence "solid" phase formation in models of stratum corneum intercellular membranes. Langmuir. 2007 May 8;23(10):5548-56. Epub 2007 Apr 3.
  8. de Gannes GC, Ghoreishi M, Pope J, Russell A, Bell D, Adams S, Shojania K, Martinka M, Dutz JP. Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. Arch Dermatol. 2007 Feb;143(2):223-31.
  9. deGannes, Ghoreishi, Pope, Dutz et al. Psoriasiform Eruptions During Anti–TNF-Treatment: Psoriasis or Not? (In reply). Arch Dermatol 2007;143:1593.
  10. Dermatology Times of Canada article on CIHR-SRTC. CIHR establishes Skin Research Training Centre in Vancouver. Dermatology Times July 2007, pg1, pg6.
  11. Dutz JP. Tumor necrosis factor-a inhibition and palmoplantar pustulosis: Janus-faced therapy? J Rheumatol. 2007 Feb;34(2):247-9.
  12. Gelfer A, Rivers JK. Long-term Follow-up of a Patient With Eruptive Melanocytic Nevi After Stevens-Johnson Syndrome. Arch Dermatol. 2007;143(12):1555-1557
  13. Guenther L, Lynde C, and Ho V. Practical Considerations for the Initiation and Maintenance of Etanercept in the Treatment of Psoriasis. J Cutan Med Surg 2007 11(Suppl 1) S37-S47.
  14. Hamzavi I, Tan E, Shapiro J, Lui H. A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women. J Am Acad Dermatol 2007;57:54-9
  15. Kalia S, Adams S. Can you identify this skin condition? Canadian Family Physician, 53: January 2007; 48-49.
  16. Kalia S, Dutz JP. New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther. 2007 Jul-Aug;20(4):160-74.
  17. Karst AM, Li G. BH3-only proteins in tumorigenesis and malignant melanoma. Cell Mol Life Sci. 2007 Feb;64(3):318-30.
  18. Krueger H, Williams D, Kaminsky B, McLean D. The Health Impact of Smoking and Obesity and What to Do About It. University of Toronto Press, Toronto - Buffalo - London, 342 Pages. Hardcover, softcover. ISBN-10: 0802094414, ISBN-13: 978-0802094414
  19. Kuo WH, Wang Y, Wong RP, Campos EI, Li G. The ING1b tumor suppressor facilitates nucleotide excision repair by promoting chromatin accessibility to XPA. Exp Cell Res. 2007 May 1;313(8):1628-38. Epub 2007 Feb 22.
  20. Liang Y, Yang S, Zhou Y, Gui J, Ren Y, Chen J, Fan X, Sun L, Xiao F, Gao M, Du W, Fang Q, Xu S, Huang W, Zhang X. Evidence for two susceptibility loci on chromosomes 22q12 and 6p21-p22 in Chinese generalized vitiligo families. J Invest Dermatol. 2007 Nov;127(11):2552-7. Epub 2007 Jun 14.
  21. Malcolm CE, Bergman JN. Trying to keep ahead of lice: a therapeutic challenge. Skin Therapy Lett. 2006 Dec-2007 Jan;11(10):1-6.
  22. Martinka M, Bruecks AK, Trotter MJ. Histologic spectrum of melanocytic nevi removed from patients > 60 years of age. J Cutan Med Surg. 2007 Sep-Oct;11(5):168-73.
  23. Monheit G, Carruthers A, Brandt F, Rand R. A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose. Dermatol Surg. 2007 Jan;33(1 Spec No.):S51-9.
  24. Otberg N, Finner AM, Shapiro J. Androgenetic alopecia. Endocrinol Metab Clin North Am. 2007 Jun;36(2):379-98.
  25. Poulin Y, Gupta A, Amiss J. Efficacy of Etanercept in the Management of Plaque Psoriasis and Psoriatic Arthritis. J Cutan Med Surg 2007, 11;Suppl 1 (April): S14-S22.
  26. Prendiville J, Rogers M, Kan A, de Castro F, Wong M, Junker A, Becknell C, Schultz K. Pigmented Hypertrichotic Dermatosis and Insulin Dependent Diabetes: Manifestations of a Unique Genetic Disorder? Pediatr Dermatol. 2007 Mar-Apr;24(2):101-7.
  27. Rice G, Patrick T. Parmar R, Taylor CF, Prendiville J, et al. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet. 2007 Oct;81(4):713-25.
  28. Rivers, JK. Hair Care. Skin Ther Lett. Family Practice Edition 2007; 3(4): 1-3.
  29. Rivers JK, Wolf J. Letter to the Editor: Assessing clinically meaningful end points for the management of actinic keratosis with diclofenac 3% gel. Acta Derm Venereol. 2007;87(2):188-9.
  30. Shapiro J. Clinical practice. Hair loss in women. N Engl J Med. 2007 Oct 18;357(16):1620-30.
  31. Short MA, Lui H, McLean D, Zeng H, Alajlan A, Chen XK. Changes in nuclei and peritumoral collagen within nodular basal cell carcinomas via confocal micro-Raman spectroscopy. J Biomed Opt. 2006 May-Jun;11(3):34004.
  32. Sinha R, Al-AlSheikh K, Prendiville J, Magil A, Matsell D.
    Quiz page. Acute rheumatic fever with concomitant poststreptococcal glomerulonephritis. Am J Kidney Dis. 2007 Jul;50(1):A33-5.
  33. Solish N, Bertucci V, Dansereau A, Hong HC, Lynde C, Lupin M, Smith KC, Storwick G; Canadian Hyperhidrosis Advisory Committee. A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol Surg. 2007 Aug;33(8):908-23.
  34. Somani N, Martinka M, Crawford RI, Dutz JP, Rivers JK. Treatment of atypical nevi with imiquimod 5% cream. Arch Dermatol. 2007 Mar;143(3):379-85.
  35. Tan JK, Tang J, Fung K, Gupta AK, Thomas DR, Sapra S, Lynde C, Poulin Y, Gulliver W, Sebaldt RJ. Development and Validation of a Comprehensive Acne Severity Scale. J Cutan Med Surg. 2007 Nov-Dec;11(6):211-6.
  36. Tan JK, Thomas DR, Poulin Y, Maddin F, Tang J. Efficacy of Imiquimod as an Adjunct to Cryotherapy for Actinic Keratoses. J Cutan Med Surg. 2007 Nov-Dec;11(6):195-201.
  37. Zhao J, Lui H, McLean DI, Zeng H. Automated Autofluorescence Background Subtraction Algorithm for Biomedical Raman Spectroscopy. Appl Spectrosc. 2007 Nov;61(11):1225-32.
  38. Zhao J, Lui H, McLean DI, Zeng H. Toward instrument-independent quantitative measurement of fluorescence intensity in fiber-optic spectrometer systems. Appl Opt. 2007 Oct 10;46(29):7132-40
  39. Zhou Y. Treatment Options for Excessive Sweating and Hyperhidrosis. Skin Ther Lett (Family Practice ed) 2007; 3;1h: 6-7.

 

 

« Back to Publications & Reports

12.10.07
 
 
©2010 University of British Columbia | Terms of Use | Privacy Policy